The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Collateral sensitivity of antibiotic-resistant microbes
Open accessAbstract
Understanding how evolution of microbial resistance towards a given antibiotic influences susceptibility to other drugs is a challenge of profound importance. By combining laboratory evolution, genome sequencing, and functional analyses, recent works have charted the map of evolutionary trade-offs between antibiotics and have explored the underlying molecular mechanisms. Strikingly, mutations that caused multidrug resistance in bacteria simultaneously enhanced sensitivity to many other unrelated drugs (collateral sensitivity). Here, we explore how this emerging research sheds new light on resistance mechanisms and the way it could be exploited for the development of alternative antimicrobial strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., et al. (2012) · JAMA · doi:10.1001/jama.2012.7961 · Cited by 2,469
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Lehár, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short III, G. F., Staunton, J. E., Jin, X., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1549 · Cited by 938
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection
Toprak, E., Veres, A., Michel, J.-B., Chait, R., Hartl, D. L., & Kishony, R. (2012) · Nature Genetics · doi:10.1038/ng.1034 · Cited by 764
The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosis
Gagneux, S., Long, C. D., Small, P. M., Van, T., Schoolnik, G. K., & Bohannan, B. J. M. (2006) · Science · doi:10.1126/science.1124410 · Cited by 627
Bacterial stress responses as determinants of antimicrobial resistance
Poole, K. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks196 · Cited by 519
Imamovic, L., & Sommer, M. O. A. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006609 · Cited by 444
Szybalski, W., & Bryson, V. (1952) · Journal of Bacteriology · doi:10.1128/jb.64.4.489-499.1952 · Cited by 421
Transcriptome analysis of all two‐component regulatory system mutants of Escherichia coli K‐12
Oshima, T., Aiba, H., Masuda, Y., Kanaya, S., Sugiura, M., Wanner, B. L., Mori, H., & Mizuno, T. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03170.x · Cited by 375
Bacterial evolution of antibiotic hypersensitivity
Lázár, V., Pal Singh, G., Spohn, R., Nagy, I., Horváth, B., Hrtyan, M., Busa‐Fekete, R., Bogos, B., Méhi, O., Csörgő, B., et al. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.57 · Cited by 350
Self-citationFitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
Vincent, B. M., Lancaster, A. K., Scherz-Shouval, R., Whitesell, L., & Lindquist, S. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001692 · Cited by 322 · cited 2×
“As a consequence, strains carrying these mutations were hypersensitive to oxidative stress, temperature, and killing by neutrophils, and they also had defects in filamentation and tissue invasion [29].”
BackgroundCollateral sensitivity as a strategy against cancer multidrug resistance
Pluchino, K. M., Hall, M. D., Goldsborough, A. S., Callaghan, R., & Gottesman, M. M. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.03.002 · Cited by 305
An experimental test of evolutionary trade-offs during temperature adaptation
Bennett, A. F., & Lenski, R. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702117104 · Cited by 285
Oz, T., Guvenek, A., Yildiz, S., Karaboga, E., Tamer, Y. T., Mumcuyan, N., Ozan, V. B., Senturk, G. H., Cokol, M., Yeh, P., et al. (2014) · Molecular Biology and Evolution · doi:10.1093/molbev/msu191 · Cited by 275
Prediction of antibiotic resistance by gene expression profiles
Suzuki, S., Horinouchi, T., & Furusawa, C. (2014) · Nature Communications · doi:10.1038/ncomms6792 · Cited by 267
Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance
Kim, S., Lieberman, T. D., & Kishony, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409800111 · Cited by 264
Biological cost and compensatory evolution in fusidic acid‐resistant Staphylococcus aureus
Nagaev, I., Björkman, J., Andersson, D. I., & Hughes, D. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02389.x · Cited by 257
Lázár, V., Nagy, I., Spohn, R., Csörgő, B., Györkei, Á., Nyerges, Á., Horváth, B., Vörös, A., Busa-Fekete, R., Hrtyan, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5352 · Cited by 249
Self-citationAn RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus
Cui, L., Isii, T., Fukuda, M., Ochiai, T., Neoh, H.-M., Camargo, I. L. B. D. C., Watanabe, Y., Shoji, M., Hishinuma, T., & Hiramatsu, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00437-10 · Cited by 206
Role of the membrane potential in bacterial resistance to aminoglycoside antibiotics
Damper, P. D., & Epstein, W. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.20.6.803 · Cited by 180
Munck, C., Gumpert, H. K., Wallin, A. I. N., Wang, H. H., & Sommer, M. O. A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009940 · Cited by 178
Dragosits, M., Mozhayskiy, V., Quiñones-Soto, S., Park, J., & Tagkopoulos, I. (2013) · Molecular Systems Biology · doi:10.1038/msb.2012.76 · Cited by 169
Opposing effects of target overexpression reveal drug mechanisms
Palmer, A. C., & Kishony, R. (2014) · Nature Communications · doi:10.1038/ncomms5296 · Cited by 162
Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro
Heisig, P., & Tschorny, R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1284 · Cited by 132
Physiology and Antibiotic Susceptibility of Staphylococcus aureus Small Colony Variants
Baumert, N., von Eiff, C., Schaaff, F., Peters, G., Proctor, R. A., & Sahl, H.-G. (2002) · Microbial Drug Resistance · doi:10.1089/10766290260469507 · Cited by 130
Molecular analysis of fusidic acid resistance in Staphylococcus aureus
Besier, S. M., Ludwig, A., Brade, V., & Wichelhaus, T. A. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03307.x · Cited by 116
Webber, M. A., Ricci, V., Whitehead, R. N., Patel, M. P., Fookes, M. C., Ivens, A. C., & Piddock, L. J. V. (2013) · mBio · doi:10.1128/mbio.00273-13 · Cited by 103
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria
Gogtay, N., Kannan, S., Thatte, U. M., Olliaro, P., & Sinclair, D. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008492.pub3 · Cited by 101
Martinez, M. N., & Silley, P. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-10324-7_10 · Cited by 97
Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax
Hastings, M. D., & Sibley, C. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182295999 · Cited by 97
gyrA Mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli
Conrad, S., Saunders, J. R., Oethinger, M. D., Kaifel, K., Klotz, G., Marre, R., & Kern, W. V. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.3.443 · Cited by 83
Lukens, A. K., Ross, L. S., Heidebrecht, R. W., Gamo, F., Lafuente-Monasterio, M. J., Booker, M. L., Hartl, D. L., Wiegand, R. C., & Wirth, D. F. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320886110 · Cited by 63
TheErwinia chrysanthemi3937 PhoQ Sensor Kinase Regulates Several Virulence Determinants
Venkatesh, B., Babujee, L., Liu, H., Hedley, P. E., Fujikawa, T., Birch, P. R. J., Toth, I. K., & Tsuyumu, S. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.8.3088-3098.2006 · Cited by 61
Fusidic acid‐resistant EF‐G perturbs the accumulation of ppGpp
Mačvanin, M., Johanson, U., Ehrenberg, M., & Hughes, D. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01967.x · Cited by 49
Prevention of Drug Resistance by Combined Drug Treatment of Tuberculosis
Mitchison, D. A. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-28951-4_6 · Cited by 29
Velicer, G. J., Schmidt, T. M., & Lenski, R. E. (1999) · Microbial Ecology · doi:10.1007/s002489900169 · Cited by 18
Cited by
Emerging contaminants: A One Health perspective
Wang, F., Xiang, L., Sze-Yin Leung, K., Elsner, M., Zhang, Y., Guo, Y., Pan, B., Sun, H., An, T., Ying, G., et al. (2024) · The Innovation · doi:10.1016/j.xinn.2024.100612 · Cited by 639
The rapid spread of carbapenem-resistant Enterobacteriaceae
Potter, R. F., D’Souza, A. W., & Dantas, G. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.09.002 · Cited by 403
Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides
Lázár, V., Martins, A., Spohn, R., Daruka, L., Grézal, G., Fekete, G., Számel, M., Jangir, P. K., Kintses, B., Csörgő, B., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0164-0 · Cited by 375
Self-citationAntibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
Domalaon, R., Idowu, T., Zhanel, G. G., & Schweizer, F. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00077-17 · Cited by 285
Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution
Bollenbach, T. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.05.008 · Cited by 261
Metadata
- Authors
- Pál, C., Papp, B., & Lázár, V.
- Venue
- Trends in Microbiology
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 23
- Issue
- 7
- Pages
- 401-407
- ISSN
- 0966-842X (ISSN-L)
- OpenAlex
- W2164782185
- Cited by
- 270
- References
- 35
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.